Journal of the American Veterinary Medical Association · 2025
Ureteroneocystostomy as a treatment for benign ureteral obstruction and ectopic ureter in cats: 37 cases.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Billas Alison, Aronson Lillian
Аннотация
OBJECTIVE: To report complications and outcomes following ureteroneocystostomy performed in cats presenting for benign ureteral obstruction or ectopic ureters.
METHODS: This was a retrospective, single-institution study of 37 cats. Medical records were reviewed for pre-, intra-, and postoperative variables including preexisting disease, pre- and postoperative bloodwork, location and source of obstruction, surgical technique, ureteral stent placement, postoperative clinical signs, and survival time. Follow-up was ≥ 14 days or until death. The Kaplan-Meier method was used to calculate median survival, and univariable and multivariable logistic regression was used to examine correlation of variables with postoperative complications and mortality.
RESULTS: Overall median survival was 1,980 days, with 92% of cats surviving to discharge. There was no intraoperative mortality and a relatively low incidence of short- (19%) and long-term (24%) complications. Highest mortality rate was within the first 30 days. Factors associated with increased mortality were increased preoperative BUN, creatinine, and phosphorous. Surgical ureteral stent removal occurred in 86% (6 of 7) of cases when placed, secondary to long-term recurrent urinary tract infections and stent migration.
CONCLUSIONS: Ureteroneocystostomy was a viable treatment option for benign obstructions and extramural ectopic ureters in cats, with overall longer median survival and lower long-term complication incidence compared to historical subcutaneous ureteral bypass device and ureteral stent literature. Preoperative azotemia was associated with poorer outcomes. Ureteral stents were associated with long-term complications, prompting removal.
CLINICAL RELEVANCE: Ureteroneocystostomy should be highly considered as a treatment option for cats presenting with benign ureteral obstructions and ectopic ureters.
METHODS: This was a retrospective, single-institution study of 37 cats. Medical records were reviewed for pre-, intra-, and postoperative variables including preexisting disease, pre- and postoperative bloodwork, location and source of obstruction, surgical technique, ureteral stent placement, postoperative clinical signs, and survival time. Follow-up was ≥ 14 days or until death. The Kaplan-Meier method was used to calculate median survival, and univariable and multivariable logistic regression was used to examine correlation of variables with postoperative complications and mortality.
RESULTS: Overall median survival was 1,980 days, with 92% of cats surviving to discharge. There was no intraoperative mortality and a relatively low incidence of short- (19%) and long-term (24%) complications. Highest mortality rate was within the first 30 days. Factors associated with increased mortality were increased preoperative BUN, creatinine, and phosphorous. Surgical ureteral stent removal occurred in 86% (6 of 7) of cases when placed, secondary to long-term recurrent urinary tract infections and stent migration.
CONCLUSIONS: Ureteroneocystostomy was a viable treatment option for benign obstructions and extramural ectopic ureters in cats, with overall longer median survival and lower long-term complication incidence compared to historical subcutaneous ureteral bypass device and ureteral stent literature. Preoperative azotemia was associated with poorer outcomes. Ureteral stents were associated with long-term complications, prompting removal.
CLINICAL RELEVANCE: Ureteroneocystostomy should be highly considered as a treatment option for cats presenting with benign ureteral obstructions and ectopic ureters.